Moringa Oleifera vs Sodium Hypochlorite for Root Canal Irrigation in Nonvital Primary Molars
Launched by CAIRO UNIVERSITY · May 10, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different solutions used during dental treatments for children with unhealthy primary (baby) molars that need to be cleaned out—specifically, Moringa Oleifera leaf extract and sodium hypochlorite. These solutions are used to help kill harmful bacteria in the tooth. The study will measure how well each solution works by checking the reduction of bacteria in the tooth after treatment.
To participate in this trial, children must be between 4 to 7 years old and have been diagnosed with specific dental issues that require treatment. They should be healthy and able to cooperate during the dental procedure. However, children with certain dental conditions or those who are unwell may not be able to join. If eligible, participants can expect to receive routine dental care while contributing to important research that could help improve treatments for kids in the future. This trial is not yet recruiting participants, so there will be more information available once it begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 4 to 7 years
- • Clinically and radiographically diagnosed with nonvital primary molars requiring pulpectomy
- • Cooperative children who can undergo dental treatment
- • Healthy-appearing children with no systemic, physical, or mental disorders
- Exclusion Criteria:
- • Medically compromised or uncooperative children
- * Primary molars indicated for extraction due to:
- • Advanced root resorption (more than two-thirds)
- • Teeth near exfoliation
- • Deep subgingival caries preventing proper restoration
- • Excessive mobility (Miller's Grade 2 or higher)
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported